BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 31607598)

  • 1. A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes.
    Ciosi M; Maxwell A; Cumming SA; Hensman Moss DJ; Alshammari AM; Flower MD; Durr A; Leavitt BR; Roos RAC; ; ; Holmans P; Jones L; Langbehn DR; Kwak S; Tabrizi SJ; Monckton DG
    EBioMedicine; 2019 Oct; 48():568-580. PubMed ID: 31607598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington's disease knock-in mice is blocked by Mlh1 knock-out.
    Loupe JM; Pinto RM; Kim KH; Gillis T; Mysore JS; Andrew MA; Kovalenko M; Murtha R; Seong I; Gusella JF; Kwak S; Howland D; Lee R; Lee JM; Wheeler VC; MacDonald ME
    Hum Mol Genet; 2020 Nov; 29(18):3044-3053. PubMed ID: 32876667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to Sequence the HTT CAG Repeat Expansion and Quantify Repeat Length Variation.
    Ciosi M; Cumming SA; Chatzi A; Larson E; Tottey W; Lomeikaite V; Hamilton G; Wheeler VC; Pinto RM; Kwak S; Morton AJ; Monckton DG
    J Huntingtons Dis; 2021; 10(1):53-74. PubMed ID: 33579864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset.
    ;
    Cell; 2019 Aug; 178(4):887-900.e14. PubMed ID: 31398342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease.
    Aldous SG; Smith EJ; Landles C; Osborne GF; Cañibano-Pico M; Nita IM; Phillips J; Zhang Y; Jin B; Hirst MB; Benn CL; Bond BC; Edelmann W; Greene JR; Bates GP
    Brain; 2024 May; 147(5):1784-1798. PubMed ID: 38387080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeat.
    Goold R; Flower M; Moss DH; Medway C; Wood-Kaczmar A; Andre R; Farshim P; Bates GP; Holmans P; Jones L; Tabrizi SJ
    Hum Mol Genet; 2019 Feb; 28(4):650-661. PubMed ID: 30358836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.
    Wright GEB; Black HF; Collins JA; Gall-Duncan T; Caron NS; Pearson CE; Hayden MR
    Lancet Neurol; 2020 Nov; 19(11):930-939. PubMed ID: 33098802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.
    Wright GEB; Collins JA; Kay C; McDonald C; Dolzhenko E; Xia Q; Bečanović K; Drögemöller BI; Semaka A; Nguyen CM; Trost B; Richards F; Bijlsma EK; Squitieri F; Ross CJD; Scherer SW; Eberle MA; Yuen RKC; Hayden MR
    Am J Hum Genet; 2019 Jun; 104(6):1116-1126. PubMed ID: 31104771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington's disease mice: genome-wide and candidate approaches.
    Pinto RM; Dragileva E; Kirby A; Lloret A; Lopez E; St Claire J; Panigrahi GB; Hou C; Holloway K; Gillis T; Guide JR; Cohen PE; Li GM; Pearson CE; Daly MJ; Wheeler VC
    PLoS Genet; 2013 Oct; 9(10):e1003930. PubMed ID: 24204323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease.
    Ferguson R; Goold R; Coupland L; Flower M; Tabrizi SJ
    Am J Hum Genet; 2024 Jun; 111(6):1165-1183. PubMed ID: 38749429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated huntingtin gene CAG nucleotide repeat size in individuals with Lynch syndrome.
    Dalene Skarping K; Arning L; Petersén Å; Nguyen HP; Gebre-Medhin S
    Sci Rep; 2024 Feb; 14(1):4300. PubMed ID: 38383663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
    Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
    JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for Assessing DNA Repair and Repeat Expansion in Huntington's Disease.
    Massey T; McAllister B; Jones L
    Methods Mol Biol; 2018; 1780():483-495. PubMed ID: 29856032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair in the trinucleotide repeat disorders.
    Jones L; Houlden H; Tabrizi SJ
    Lancet Neurol; 2017 Jan; 16(1):88-96. PubMed ID: 27979358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Detection and Sizing of the HTT CAG Repeat Expansion in Huntington Disease Using an Improved Triplet-Primed PCR Assay.
    Zhao M; Lee CG; Law HY; Chong SS
    Neurodegener Dis; 2016; 16(5-6):348-51. PubMed ID: 27207688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAN1 controls mismatch repair complex assembly via MLH1 retention to stabilize CAG repeat expansion in Huntington's disease.
    Goold R; Hamilton J; Menneteau T; Flower M; Bunting EL; Aldous SG; Porro A; Vicente JR; Allen ND; Wilkinson H; Bates GP; Sartori AA; Thalassinos K; Balmus G; Tabrizi SJ
    Cell Rep; 2021 Aug; 36(9):109649. PubMed ID: 34469738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-, tissue- and length-dependent bidirectional somatic CAG•CTG repeat instability in an allelic series of R6/2 Huntington disease mice.
    Larson E; Fyfe I; Morton AJ; Monckton DG
    Neurobiol Dis; 2015 Apr; 76():98-111. PubMed ID: 25662336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CAG Repeat Length in the Huntington Gene With Cognitive Performance in Young Adults.
    Schultz JL; Saft C; Nopoulos PC
    Neurology; 2021 May; 96(19):e2407-e2413. PubMed ID: 33692166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A probable
    Dawson J; Baine-Savanhu FK; Ciosi M; Maxwell A; Monckton DG; Krause A
    HGG Adv; 2022 Oct; 3(4):100130. PubMed ID: 35935919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases.
    Bettencourt C; Hensman-Moss D; Flower M; Wiethoff S; Brice A; Goizet C; Stevanin G; Koutsis G; Karadima G; Panas M; Yescas-Gómez P; García-Velázquez LE; Alonso-Vilatela ME; Lima M; Raposo M; Traynor B; Sweeney M; Wood N; Giunti P; ; Durr A; Holmans P; Houlden H; Tabrizi SJ; Jones L
    Ann Neurol; 2016 Jun; 79(6):983-90. PubMed ID: 27044000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.